Much criticized Mallinckrodt bows out of PhRMA ahead of some tightened restrictions on membership
Just ahead of some new, more muscular rules governing who can be a part of the industry lobbying organization PhRMA, one of its most heavily …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
